Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1999
11/17/1999EP0956043A1 Strain selection of pneumococcal surface proteins
11/17/1999EP0956031A1 Inhibition of 26s and 20s proteasome by indanones
11/17/1999EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999EP0741726B1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/17/1999CN1235596A Cyclic amine derivatives
11/17/1999CN1235553A Use of GLP-1 or analogs in treatment of myocardial infraction
11/17/1999CN1235548A Method for lowering plasma levels of lipoprotein (A)
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235512A Method for treating endothelial injury
11/17/1999CN1235052A Capsule for regeneration of heart valves
11/17/1999CN1235047A Prescription of Tongshuanjiangyawan as hypotensor and thrombolytic medicine and preparing method thereof
11/17/1999CN1234976A Method for extracting sulphur containing part from garlic and preparation of oil containing sulphur part
11/17/1999CN1046525C Compounds containing fused bicyclic ring and preparation thereof
11/17/1999CN1046518C Heterocyclic subtituted imidazoloquinoxalinones, preparation and use thereof
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/17/1999CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/17/1999CN1046507C Heterocyclic compounds for treatment of CNS and cardiovasular disorders
11/16/1999US5986103 2-alkyl-1H-imidazole-5-carboxylic acids
11/16/1999US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof
11/16/1999US5986055 CDK2 interactions
11/16/1999US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985915 Cardiovascular disorders such as arrhythmia
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985886 Endothelin receptor antagonists
11/16/1999US5985885 Useful in the treatment of hypertension, congestive heart failure, prostate hypertrophy, various urinary tract disorders and pathological symptoms caused by hyperactivity or disfunctioning of the noradrenergic neural system
11/16/1999US5985878 Angiogenesis inhibiting pyridazinamines
11/16/1999US5985873 Useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to human neuropeptide y1
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985845 Methods for reducing mortality rates in poultry
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/16/1999CA2088761C Benzimidazole derivatives, process for their preparation and application
11/16/1999CA2064815C Therapeutic heterocyclic compounds
11/16/1999CA2013599C Aryl-substituted rhodanine derivatives
11/16/1999CA1340824C Neurokinin a antagonists
11/14/1999CA2270022A1 Combination of dofetilide and a calcium channel blocker
11/13/1999CA2248987A1 Novel compounds
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057146A1 Protein mixtures to induce therapeutic angiogenesis
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057113A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999WO1999057102A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999057096A1 Biphenyl derivatives
11/11/1999WO1999056783A1 Hydrogel for the therapeutic treatment of aneurysms
11/11/1999WO1999056766A2 Method for treating ischemia
11/11/1999WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999WO1999056743A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations
11/11/1999WO1999056734A2 Transdermal therapeutic system for the administration of candesartan
11/11/1999WO1999047677A3 Polypeptides homologous to vegf and bmp1
11/11/1999WO1999047563A3 Ribonucleotide polypeptides containing metal
11/11/1999WO1999046240A3 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999WO1999043354A3 Method for treating painful conditions of the anal region and compositions therefor
11/11/1999WO1999042574B1 Sequences of an ih ionic channel and the use thereof
11/11/1999DE19838506A1 Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen The indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferations
11/11/1999DE19820151A1 Transdermales therapeutisches System zur Anwendung von Candesartan Transdermal therapeutic system for application of candesartan
11/11/1999DE19820064A1 Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted Sulfonylcyanamide, processes for their preparation and their use as a medicament
11/11/1999DE19818955A1 Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat Composition containing polyacrylate, polyterpene, nitroglycerin, and optionally, polyvinyl acetate
11/11/1999CA2331863A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2330665A1 Protein mixtures to induce therapeutic angiogenesis
11/11/1999CA2329704A1 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328732A1 Biphenyl derivatives
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999CA2325387A1 Method for treating ischemia
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955301A2 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
11/10/1999EP0955294A2 Imidazolyl-alkenoic acid
11/10/1999EP0955049A2 6 Beta-Hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 ene - 3,20 - dione, as an inhibitor of smooth muscle proliferation
11/10/1999EP0954588A1 Ob fusion protein compositions and methods
11/10/1999EP0954575A2 Cerebellum and embryo specific protein
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954521A1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954308A1 Therapeutic treatment for cardiovascular diseases
11/10/1999EP0954306A1 Methods of increasing nitric oxide synthesis
11/10/1999EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999EP0776208B1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
11/10/1999CN1234835A Gene therapy for congestive heart failure
11/10/1999CN1234804A Process for preparing pharmacologically acceptable salts of N-(1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids
11/10/1999CN1234803A N heterocyclic substituted adenosine derivatives
1 ... 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 ... 1595